Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Current Pharmaceutical Biotechnology
|
November 17, 2010
Current strategies in lead discovery
Maria L Webb
Combinatorial Chemistry & High Throughput Screening
|
June 22, 2006
Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitors
Axel Metzger, David J Diller, Tsung H Lin, et al.
Expert Opinion on Therapeutic Targets
|
June 17, 2008
Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges
Laura L Rokosz, James R Beasley, Carolyn Diianni Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 17, 2006
Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors
Tsung H Lin, Axel Metzger, David J Diller, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2007
Discovery and preliminary evaluation of 5-(4-phenylbenzyl)oxazole-4-carboxamides as prostacyclin receptor antagonists
Marc-Raleigh Brescia, Laura L Rokosz, Andrew G Cole, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2002
Biphenylsulfonamide endothelin receptor antagonists. Part 3: structure-activity relationship of 4'-heterocyclic biphenylsulfonamides
Natesan Murugesan, Zhengxiang Gu, Philip D Stein, et al.
Biochemical and Biophysical Research Communications
|
August 26, 2006
Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries
Ilana L Stroke, Andrew G Cole, Srilatha Simhadri, et al.
FEBS Letters
|
February 13, 2008
Identification and characterization of small-molecule inhibitors of Tie2 kinase
Jinqi Liu, Tsung H Lin, Andrew G Cole, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2008
Synthesis and initial evaluation of novel, non-peptidic antagonists of the alpha(v)-integrins alpha(v)beta(3) and alpha(v)beta(5)
Jeffrey J Letourneau, Jinqi Liu, Michael H J Ohlmeyer, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 11, 2005
Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists
Andrew G Cole, Ilana L Stroke, Marc-Raleigh Brescia, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Current Pharmaceutical Biotechnology
|
November 17, 2010
Current strategies in lead discovery
Maria L Webb
Combinatorial Chemistry & High Throughput Screening
|
June 22, 2006
Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitors
Axel Metzger, David J Diller, Tsung H Lin, et al.
Expert Opinion on Therapeutic Targets
|
June 17, 2008
Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges
Laura L Rokosz, James R Beasley, Carolyn Diianni Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 17, 2006
Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors
Tsung H Lin, Axel Metzger, David J Diller, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2007
Discovery and preliminary evaluation of 5-(4-phenylbenzyl)oxazole-4-carboxamides as prostacyclin receptor antagonists
Marc-Raleigh Brescia, Laura L Rokosz, Andrew G Cole, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2002
Biphenylsulfonamide endothelin receptor antagonists. Part 3: structure-activity relationship of 4'-heterocyclic biphenylsulfonamides
Natesan Murugesan, Zhengxiang Gu, Philip D Stein, et al.
Biochemical and Biophysical Research Communications
|
August 26, 2006
Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries
Ilana L Stroke, Andrew G Cole, Srilatha Simhadri, et al.
FEBS Letters
|
February 13, 2008
Identification and characterization of small-molecule inhibitors of Tie2 kinase
Jinqi Liu, Tsung H Lin, Andrew G Cole, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2008
Synthesis and initial evaluation of novel, non-peptidic antagonists of the alpha(v)-integrins alpha(v)beta(3) and alpha(v)beta(5)
Jeffrey J Letourneau, Jinqi Liu, Michael H J Ohlmeyer, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 11, 2005
Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists
Andrew G Cole, Ilana L Stroke, Marc-Raleigh Brescia, et al.
Page
of 3